NovoCure Limited (NVCR)
NASDAQ: NVCR
· Real-Time Price · USD
19.11
-0.29 (-1.49%)
At close: May 30, 2025, 3:59 PM
19.11
0.01%
After-hours: May 30, 2025, 04:21 PM EDT
-1.49% (1D)
| Bid | 18.02 |
| Market Cap | 2.13B |
| Revenue (ttm) | 621.71M |
| Net Income (ttm) | -164.19M |
| EPS (ttm) | -1.52 |
| PE Ratio (ttm) | -12.57 |
| Forward PE | -11.07 |
| Analyst | Buy |
| Ask | 20.24 |
| Volume | 846,628 |
| Avg. Volume (20D) | 966,989.1 |
| Open | 19.27 |
| Previous Close | 19.40 |
| Day's Range | 18.46 - 19.29 |
| 52-Week Range | 14.17 - 34.13 |
| Beta | 0.73 |
About NVCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-12.43%
NovoCure shares are trading lower after the compan...
Unlock content with
Pro Subscription
5 months ago
+11.14%
NovoCure shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $28 to $42.
